Scientific Solutions business splits from global medtech company TOKYO, Japan—Olympus Corporation (“Olympus”) announced the completion of the separation of its Scientific Solutions business to a wholly-owned subsidiary, Evident Corporation (“Evident”). Following the divestiture of its Imaging business, this move further signifies the company’s long-term strategy to cement its position as a major player in the […]
New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics WALTHAM, Mass.–Apr. 4, 2022– PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced two ready-to-use HTRF® and AlphaLISA® no-wash assay kits designed to quickly and easily detect and quantify CHO HCP impurities during biopharmaceutical […]
IKA launches bioreactor for laboratories Staufen – IKA-Works is bringing a new bioreactor into the market. HABITAT enables the reproducible and standardized cultivation of a wide variety of cell types. It is a bioreactor, photobioreactor and fermenter in one and sets new standards with its ergonomic and efficient operation. Whether mixing, temperature control, automation, safety […]
AddLife is continuing its expansion in Europe by acquiring BioCat GmbH (“BioCat”), for inclusion in its Labtech business area. BioCat is a specialized distributor of products and services to the life science research market with annual revenues of EUR 9m. The company is located in Germany but also has sales in Austria and Switzerland, giving […]
Wetzlar, Germany – Leica Microsystems, a leading manufacturer of microscopes and scientific instruments, has announced the appointment of Dr. Annette Rinck as its President, with effect from 1 April 2022. Annette succeeds Markus Lusser, who was promoted to a new Life Sciences position within Danaher Corporation, Leica’s parent company. Annette joins Leica from Honeywell where […]
BD Rhapsody™ TCR/BCR Multiomic Assay speeds discovery in autoimmune disorders, immuno-oncology and infectious diseases FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, recently released the BD Rhapsody™ TCR/BCR Multiomic Assay, an innovative set of reagents that enables researchers to more easily and comprehensively analyze important cells in […]
Cytosurge, a global leader in precision single cell manipulation, today announced the launch of FluidFM® CellEDIT, a CRISPR cell line engineering service based on its FluidFM® technology. Zurich | Genetically engineered cell lines have become an invaluable tool in biological research and drug discovery. Nobel-prize winning CRISPR technology has opened up multiple opportunities for […]
Recently, China’s leading company in animal cell culture technology and domestic serum-free culture media, Shanghai BioEngine Sci-Tech Co., LTD, announced the completion of a 200 million RMB Series B++ financing round. The financing was led by Legend Capital, followed by Addor Capital and Tsing Song Capital, and the old shareholder Hankang Capital continued to increase […]
Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022 Fluidigm Board to Appoint Frank Witney, a Director Candidate Recommended by Caligan, if Casdin and Viking Transaction Closes Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting SOUTH SAN […]
SEATTLE — Curi Bio, a leading developer of human stem cell-based platforms and technologies for drug discovery, today announced the exclusive commercial acquisition from StemBioSys of the CarTox™ technology platform for calcium and voltage optical mapping. In parallel, Curi Bio announced it will commercialize the technology through its newly announced product: the Nautilus™ optical mapping system. By […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
